AQUINOX PHARMACEUTICALS
Aquinox Pharmaceuticals Inc., a pharmaceutical company, engages in discovery, development, and commercialization of small molecule therapeutics for the treatment of cancer and inflammatory disease. It offers AQX-MN100, a drug used to treat cancer and inflammatory disease, as well as SH2-containing inositol 5'-phosphatase inhibition program for blood cell recovery. The company was founded in 2004 and is based in Vancouver, Canada.
AQUINOX PHARMACEUTICALS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2004-01-01
Address:
Vancouver, British Columbia, Canada
Country:
Canada
Website Url:
http://www.aqxpharma.com
Total Employee:
11+
Status:
Closed
Contact:
604.629.9223
Email Addresses:
[email protected]
Total Funding:
159.37 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Domain Not Resolving GoDaddy DNS Google Google Cloud OpenResty Google Adsense Google Cloud Global Multi-Region AdBlock Acceptable Ads
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Milestone Pharmaceuticals
Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2019-08-06 | Neoleukin Therapeutics | Neoleukin Therapeutics acquired by Aquinox Pharmaceuticals | 40 M USD |
Investors List
Cowen Group
Cowen Group investment in Post-IPO Equity - Aquinox Pharmaceuticals
Johnson & Johnson Development Corporation
Johnson & Johnson Development Corporation investment in Series C - Aquinox Pharmaceuticals
Inbio Ventures
Inbio Ventures investment in Series C - Aquinox Pharmaceuticals
Pfizer Venture Investments
Pfizer Venture Investments investment in Series C - Aquinox Pharmaceuticals
Baker Brothers Advisors LLC
Baker Brothers Advisors LLC investment in Series C - Aquinox Pharmaceuticals
Ventures West
Ventures West investment in Series C - Aquinox Pharmaceuticals
Augment Investments
Augment Investments investment in Series C - Aquinox Pharmaceuticals
Pfizer Venture Investments
Pfizer Venture Investments investment in Series B - Aquinox Pharmaceuticals
Ventures West
Ventures West investment in Series B - Aquinox Pharmaceuticals
Baker Brothers Advisors LLC
Baker Brothers Advisors LLC investment in Series B - Aquinox Pharmaceuticals
Official Site Inspections
http://www.aqxpharma.com
- Host name: 89.116.72.2
- IP address: 89.116.72.2
- Location: Republic of Lithuania
- Latitude: 56
- Longitude: 24
- Timezone: Europe/Vilnius
